Экономическая эффективность использования различных типов стентов при коррекции хронических окклюзий коронарных артерий

В.И. Стельмашок
Республиканский научно-практический центр «Кардиология»
Цель. Изучить экономическую эффективность использования различных типов стентов при коррекции хронических окклюзий (ХТО) коронарных артерий.
Методы. В исследование включено 119 пациентов, которым в 2009– 2012 годах была успешно выполнена реканализация ХТО коронарных артерий. Через 6,1±0,9 месяцев и 12,7±1,6 месяцев выполнялось контрольное обследование (коронарография, внутрисосудистое ультразвуковое исследование, оптическая когерентная томография). Анализировались негативные события (внутристентовые рестенозы и тромбозы), c учетом полученных данных выполнялась калькуляция прямых затрат, включающая стоимость имплантов, расходы на лечение рестенозов и тромбозов.
ключевые слова: хронические окклюзии, коронарные артерии, рестенозы, тромбозы, экономическая эффективность.

для цитирования: В.И. Стельмашок. Экономическая эффективность использования различных типов стентов при коррекции хронических окклюзий коронарных артерий. Неотложная кардиология и кардиоваскулярные риски, 2022, Т. 6, № 2, С. 1666–1672.

Cost-effectiveness of different types of stents in the correction of chronic total occlusion
V. Stelmashok
Aim. To study cost-effectiveness of different types of stents in the correction of chronic total occlusion (CTO). Methods. The study included 119 patients after successful coronary artery CTO recanalization in 2009–2012. After 6.1±0.9 months and 12.7±1.6 months a control examination was performed (coronary angiography, intravascular ultrasound, optical coherence tomography). Negative events (in-stent restenosis and thrombosis) were analyzed. Taking into account the obtained data, direct costs were calculated including the cost of implants, and the cost of restenosis and thrombosis treatment.
keywords: chronic occlusions, coronary arteries, restenosis, thrombosis, cost-effectiveness.

for references: V. Stelmashok. Cost-effectiveness of different types of stents in the correction of chronic total occlusion. Neotlozhnaya kardiologiya i kardiovaskulyarnye riski [Emergency cardiology and cardiovascular risks], 2022, vol. 6, no. 2, pp. 1666–1672.

1. Di Mario C., Werner G.S., Sianos G., Galassi A.R., Büttner J., Dudek D., Chevalier B., Lefevre T., Schofer J., Koolen J., Sievert H., Reimers B., Fajadet J., Colombo A., Gershlick A., Serruys P.W., Reifart N. European perspective in the recanalisation of Chronic Total Occlusions (CTO): consensus document from the EuroCTO Club. EuroIntervention, 2007, vol. 3, no. 1, pp. 30-43.
2. Galassi A.R., Tomasello S.D., Reifart N., Werner G.S., Sianos G., Bonnier H., Sievert H., Ehladad S., Bufe A., Shofer J., Gershlick A., Hildick-Smith D., Escaned J., Erglis A., Sheiban I., Thuesen L., Serra A., Christiansen E., Buettner A., Costanzo L., Barrano G., Di Mario C. In-hospital outcomes of percutaneous coronary intervention in patients with chronic total occlusion: insights from the ERCTO (European Registry of Chronic Total Occlusion) registry. EuroIntervention, 2011, vol. 7, no. 4, pp. 472-479. doi: 10.4244/EIJV7I4A77.
3. Stone G.W., Kandzari D.E., Mehran R., Colombo A., Schwartz R.S., Bailey S., Moussa I., Teirstein P.S., Dangas G., Baim D.S., Selmon M., Strauss B.H., Tamai H., Suzuki T., Mitsudo K., Katoh O., Cox D.A., Hoye A., Mintz G.S., Grube E., Cannon L.A., Reifart N.J., Reisman M., Abizaid A., Moses J.W., Leon M.B., Serruys P.W. Percutaneous recanalization of chronically occluded coronary arteries: a consensus document: part I. Circulation, 2005, vol. 112, no. 15, pp. 2364-2372. doi: 10.1161/CIRCULATIONAHA.104.481283.
4. Waksman R., Saito S. Chronic total occlusions: a guide to recanalization. Chichester; Hoboken: Wiley-Blackwell, 2009. – 198 р.
5. Neumann F-J., Sousa-Uva M., Ahlsson A., Alfonso F., Banning A. P., Benedetto U., Byrne R. A., Collet J-P., Falk V., Head S. J., Jüni P., Kastrati A., Koller A., Kristensen S. D., Niebauer J., Richter D. J., Seferovic P. M., Sibbing D., Stefanini G. G., Windecker S., Yadav R., Zembala M. O . 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J, 2019, vol. 40, no. 2, pp. 87-165. doi: 10.1093/eurheartj/ehy394.
6. Werner G., Martin-Yuste V., Hildick-Smith D., Boudou N., Sianos G., Gelev V., Rumoroso J., Erglis A., Christiansen E., Escaned J., di Mario C., Hovasse T., Teruel L., Bufe A., Lauer B., Bogaerts K., Goicolea J., Spratt J., Gershlick A., Galassi A., Louvard Y. A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions. Eur Heart J, 2018, vol. 39, no. 26, pp. 2484-2493. doi: 10.1093/eurheartj/ehy220.
7. Goel P.K., Khanna R., Pandey C.M., Ashfaq R. Long-term outcomes post chronic total occlusion intervention-implications of completeness of revascularization. J Interven Cardiol, 2018, vol. 31, no. 3, pp. 293-301. doi: 10.1111/joic.12480.
8. van Dongen I.M., Yilmaz D., Elias J., Claessen B., Delewi R., Knops R. E., Wilde A., van Erven L., Schalij M. J., Henriques J. Evaluation of the impact of a chronic total coronary occlusion on ventricular arrhythmias and long-term mortality in patients with ischemic cardiomyopathy and an implantable cardioverter-defibrillator (the eCTOpy-in-ICD Study). J Am Heart Assoc, 2018, vol. 7, pp. e008609. doi: 10.1161/JAHA.118.008609.
9. Patel V.G., Brayton K.M., Tamayo A., Mogabgab O., Michael T.T., Lo N., Alomar M., Shorrock D., Cipher D., Abdullah S., Banerjee S., Brilakis E.S. Angiographic success and procedural complications in patients undergoing percutaneous coronary chronic total occlusion interventions: a weighted meta-analysis of 18,061 patients from 65 studies. JACC Cardiovasc Interv, 2013, vol. 6, no. 2, pp. 128-136. doi: 10.1016/j.jcin.2012.10.011
10. Tanaka H., Tsuchikane E., Muramatsu T., Kishi K., Muto M., Oikawa Y., Kawasaki T., Hamazaki Y., Fujita T., Katoh O. A novel algorithm for treating chronic total coronary artery occlusion. J Am Coll Cardiol, 2019, vol. 74, no. 19, pp. 2392-2404. doi: 10.1016/j.jacc.2019.08.1049.
11. Nikolsky E., Gruberg L., Rosenblatt E., Grenadier E., Boulos M., Bernstein Z., Huber A., Gitman R., Bar-Deroma R., Markiewicz W., Beyar R. Chronic total occlusion due to diffuse in-stent restenosis: is brachytherapy the solution? Int J Cardiovasc Intervent, 2004, vol.6, no. 1, pp. 33-38.
12. Huang K.N., Grandi S.M., Filion K.B., Eisenberg M.J. Late and very late stent thrombosis in patients with second-generation drug-eluting stents. Can J Cardiol, 2013, vol. 29, no. 11, pp. 1488-1494. doi: 10.1016/j.cjca.2013.04.001.
13. Stelmashok V.I. Vnutristentovoe restenozirovanie v srednesrochnom periode posle uspeshno vy’polnennoy rekanalizacii hronicheskih okklyuziy koronarny’h arteriy antegradny’m dostupom [Intra-stent restenosis in the medium term after successful recanalization of chronic coronary artery occlusions with antegrade access]. Vesci NAN Belarusi Ser med navuk, 2019, vol. 16, no. 1, pp. 65-76. (in Russian).
14. Safley D., House J., Rutherford B., Marso S. Success rates of percutaneous coronary intervention of chronic total occlusions and long-term survival in patients with diabetes mellitus. Diabetes Vasc Dis Res, 2006, vol. 3, no. 1, pp. 45-51.
15. Werner G.S., Krack A., Schwarz G., Prochnau D., Betge S., Figulla H.R. Prevention of lesion recurrence in chronic total coronary occlusions by paclitaxel-eluting stents. J Am Coll Cardiol, 2004, vol. 44, no. 12, pp. 2301-2306. doi: 10.1016/j.jacc.2004.09.040.
16. Cutlip D.E., Windecker S., Mehran R., Boam A., Cohen D.J., van Es G.-A., Steg P.G., Morel M.-A., Mauri L., Vranckx P., McFadden E., Lansky A., Hamon M., Krucoff M.W., Serruys P.W. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation, 2007, vol. 115, no. 17, pp. 2344-2351. doi: 10.1161/CIRCULATIONAHA.106.685313.
17. Koelbl C.O., Nedeljkovic Z.S., Jacobs A.K.Coronary chronic total occlusion (CTO): a review. Rev Cardiovasc Med, 2018, vol. 19, no. 1, pp. 33-39. doi: 10.31083/j.rcm.2018.01.896.
18. Hung C-S., Cheng C-L., Chao C-L., Kao H-L., Chen M-F., Lin N-P. Cost-effectiveness of drug-eluting stents in patients with stable coronary artery disease. J Formos Med Assoc, 2011, vol. 110, no. 2, pp. 109-14. doi: 10.1016/S0929-6646(11)60017-X.
19. Poder T.G., Erraji J., Coulibaly L.P., Koffi K. Percutaneous coronary intervention with second-generation drug-eluting stent versus bare-metal stent: systematic review and cost-benefit analysis. PLoS One, 2017, vol. 12, no. 5, p. e0177476. doi: 10.1371/journal.pone.0177476.
20. Pessoa J.A., Ferreira E., Araújo D.V., Maia E., da Silva F.S.M., de Oliveira M.S., de Albuquerque D.C. Cost-effectiveness of drug-eluting stents in percutaneous coronary intervention in Brazil’s Unified Public Health System (SUS). Arq Bras Cardiol, 2020, vol. 115, no. 1, pp. 80-89. doi: 10.36660/abc.20180292.
Формат файла: pdf (259.77 Кб)